ANI Pharmaceuticals
ANIP
#4819
Rank
$1.83 B
Marketcap
$81.77
Share price
-1.17%
Change (1 day)
43.53%
Change (1 year)

Revenue for ANI Pharmaceuticals (ANIP)

Revenue in 2025 (TTM): $0.82 Billion USD

According to ANI Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is $0.82 Billion USD. In 2024 the company made a revenue of $0.61 Billion USD an increase over the revenue in the year 2023 that were of $0.48 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ANI Pharmaceuticals from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $0.82 B34.59%
2024 $0.61 B26.2%
2023 $0.48 B53.87%
2022 $0.31 B46.38%
2021 $0.21 B3.67%
2020 $0.20 B0.93%
2019 $0.20 B2.47%
2018 $0.20 B13.99%
2017 $0.17 B37.49%
2016 $0.12 B68.53%
2015 $76.32 M36.36%
2014 $55.97 M126.92%
2013 $24.66 M972.06%
2012 $2.3 M428.71%
2011 $0.43 M-82.41%
2010 $2.47 M96.67%
2009 $1.25 M-66.57%
2008 $3.76 M663.29%
2007 $0.49 M-96.59%
2006 $14.43 M5488.78%
2005 $0.25 M231.7%
2004 $0.07 M
2001 $1.79 M2823.62%
2000 $0.06 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Jazz Pharmaceuticals
JAZZ
$4.15 B 402.83%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
$12.79 M-98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$16.77 B 1,928.83%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
$62.78 B 7,493.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
$0.31 B-62.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$2.6 M-99.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
$234.31 B 28,236.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$56.37 B 6,717.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
$2.34 B 184.18%๐Ÿ‡ฌ๐Ÿ‡ง UK